Advisory Committee on Immunization Methods supports the permissive usage of GARDASIL Merck & Co.

Advisory Committee on Immunization Methods supports the permissive usage of GARDASIL Merck & Co., Inc. Today that the U announced.S. The ACIP also voted to advise that funding be offered for the use of GARDASIL in men through the Vaccines for Kids program. On 16 October, the Food and Medication Administration accepted GARDASIL for use in males and males 9 through 26 years of age for the prevention of genital warts caused by HPV types 6 and 11, producing GARDASIL the just HPV vaccine authorized for make use of in males. Continue reading